Chromium picolinate shows promise for teen skin condition linked to insulin resistance

NCT ID NCT07371169

Completed Disease control Sponsor: Uruk University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether taking chromium picolinate daily for 24 weeks could reduce the severity of acanthosis nigricans (dark, thick skin patches) and improve insulin resistance in adolescents aged 12 to 18. Researchers compared the supplement to a placebo in 90 participants. The goal was to see if a simple supplement could help manage these conditions without major side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: chromium picolinate
What this could lead to: If it works, this could point toward a simple supplement to help manage skin changes and insulin resistance in teens.
What could go wrong: This is a small, completed trial with 90 participants, so results may not apply broadly. Chromium supplements can have side effects and may not be effective for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACANTHOSIS NIGRICANS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acanthosis nigricans Insulin Resistance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACANTHOSIS NIGRICANS INSULIN RESISTANCE

Contacts and locations

Locations

Baghdad Medical City / Children Welfare Teaching Hospital / Department of Endocrinology

Baghdad, Baghdad Governorate, 10045, Iraq

More trials for these conditions

Other studies related to the condition(s) this trial covers.